or Try an Advanced Search...

    Technical Analysis for IXC - Invex Therapeutics Ltd

    Grade Last Price % Change Price Change
    F 0.076 -9.52% -0.008
    IXC closed down 9.52 percent on Thursday, May 30, 2024, on 64 percent of normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IXC trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Below Lower BB Weakness 0.00%
    Gapped Down Weakness 0.00%
    Narrow Range Bar Range Contraction -9.52%
    Gapped Up Strength -9.52%
    MACD Bearish Signal Line Cross Bearish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Below Lower BB Weakness 0.00%
    Gapped Down Weakness 0.00%
    Narrow Range Bar Range Contraction -9.52%
    Older End-of-Day Signals for IXC ...

       Recent Intraday Alerts

    Alert Time
    Down 2 ATRs 22 days ago
    Down 1 ATR 22 days ago
    Fell Below Previous Day's Low 22 days ago
    Down 5% 22 days ago
    Down 3% 22 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    IXC Chart by TradingView
    Basic chart:

    Profile

    Invex Therapeutics Ltd Australia-based biopharmaceutical company that focuses on research and development of treatments for neurological conditions. The Company’s Exenatide is a glucagon-like peptide-1 receptor agonist approved for the treatment of type II diabetes. It also focuses on reformulating Exenatide to deliver it in a way that enables exploitation of its previously unknown ability to reduce cerebral spinal fluid secretion in the choroid plexus of the brain. The Company intends to progress expediently to clinical evaluation and undertake the registration of different formulations of Exenatide optimised to treat different neurological conditions.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Flu Biopharmaceutical Progress Diabetes Organ Systems Peptide Endocrine System Expedient I Diabetes Ii Diabetes

    Is IXC a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.63
    52 Week Low 0.06
    Average Volume 49,066
    200-Day Moving Average 0.170
    50-Day Moving Average 0.086
    20-Day Moving Average 0.084
    10-Day Moving Average 0.081
    Average True Range 0.004
    RSI (14) 40.83
    ADX 15.11
    +DI 26.290
    -DI 49.032
    Chandelier Exit (Long, 3 ATRs) 0.077
    Chandelier Exit (Short, 3 ATRs) 0.084
    Upper Bollinger Bands 0.091
    Lower Bollinger Band 0.076
    Percent B (%b) -0.01
    BandWidth 17.725
    MACD Line -0.002
    MACD Signal Line -0.001
    MACD Histogram -0.0004
    Fundamentals Value
    Market Cap 5.71 Million
    Num Shares 75.2 Million
    EPS -0.03
    Price-to-Earnings (P/E) Ratio -2.53
    Price-to-Sales 0.00
    Price-to-Book 2.45
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.076
    Resistance 3 (R3) 0.076 0.076 0.076
    Resistance 2 (R2) 0.076 0.076 0.076 0.076
    Resistance 1 (R1) 0.076 0.076 0.076 0.076 0.076
    Pivot Point 0.076 0.076 0.076 0.076 0.076
    Support 1 (S1) 0.076 0.076 0.076 0.076 0.076
    Support 2 (S2) 0.076 0.076 0.076 0.076
    Support 3 (S3) 0.076 0.076 0.076
    Support 4 (S4) 0.076